Articles | Open Access | https://doi.org/10.55640/

NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): METABOLIC MECHANISMS AND RISK OF PROGRESSION TO CIRRHOSIS

Absalamov Shoxjahon Axror ugli, Saytmurodova Sevinch Davronovna, Osarov Javohir Baxtiyorovich, Bozorboyev Elmurod Sherqul ugli,Fayzullayeva Dilbar Botir kizi , Samarkand State Medical University

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a prevalent chronic liver disorder characterized by excessive fat accumulation in hepatocytes in the absence of significant alcohol consumption. It is strongly associated with obesity, insulin resistance, type 2 diabetes mellitus, and metabolic syndrome. NAFLD encompasses a spectrum ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, and eventually cirrhosis. Pathophysiology involves multiple metabolic mechanisms including insulin resistance, oxidative stress, lipid peroxidation, inflammatory cytokine production, and mitochondrial dysfunction. Early identification of at-risk individuals, non-invasive assessment of fibrosis, and targeted interventions are crucial to prevent progression. Therapeutic strategies focus on lifestyle modification, management of metabolic comorbidities, pharmacologic therapies under investigation, and emerging treatments targeting hepatic inflammation and fibrosis. This article reviews the metabolic mechanisms underlying NAFLD, risk factors for progression to cirrhosis, diagnostic strategies, and current and emerging therapeutic approaches.

Keywords

Non-alcoholic fatty liver disease, NAFLD, non-alcoholic steatohepatitis, NASH, insulin resistance, metabolic syndrome, liver fibrosis, cirrhosis.

References

Karimov Sh.I., Axmedov R.A. Hepatic Manifestations of Metabolic Disorders.

Karimov Sh.I., Axmedov R.A. Hepatic Manifestations of Metabolic Disorders. Tashkent: Abu Ali ibn Sino Medical Publishing House; 2019. 290 p.

Saidov M.S., Rakhimov B.T. Clinical Approaches to Non-Alcoholic Fatty Liver Disease.

Saidov M.S., Rakhimov B.T. Internal Medicine: Liver and Metabolic Disorders. Tashkent: Yangi Asr Avlodi Publishing; 2021. 375 p.

Yuldashev A.A., Tursunov F.F. Non-Alcoholic Fatty Liver Disease: Metabolic Mechanisms and Clinical Management.

Yuldashev A.A., Tursunov F.F. Non-alcoholic fatty liver disease: metabolic mechanisms and clinical management. Medical and Time (Tibbiyot va Zamon). 2022;4(55):22–30.

American Association for the Study of Liver Diseases. Practice Guidance on Nonalcoholic Fatty Liver Disease.

Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–357.

Article Statistics

Downloads

Download data is not yet available.

Copyright License

Download Citations

How to Cite

NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): METABOLIC MECHANISMS AND RISK OF PROGRESSION TO CIRRHOSIS. (2026). International Journal of Medical Sciences, 6(02), 597-600. https://doi.org/10.55640/